Silexion Therapeutics SLXN
NASDAQ SLXN
$0.15 +0.00 (+0.52%)
At close: Oct 20, 2026 · 4:00 PM EDT

Silexion Therapeutics (SLXN) Operating Margin (2024 - 2025)

Updated

Analysis

Silexion Therapeutics (SLXN) Operating Margin (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 28.21%
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 37.86%
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 20.57%
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -133.21%
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 28.37%
10 Silexion Therapeutics 109,426.60 -19.77 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -18,333.33%
Dec 31, 2024 -7,916.67%
API Access

Silexion Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=SLXN&period=max&api_key=YOUR_API_KEY